FDA's Adverse Event Reporting System
Names
More detailed information about this field from each metasource.
FDA's Adverse Event Reporting System
metasource: Fairsharing.org
version: None
FAERS
metasource: Fairsharing.org
version: None
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
faers
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
Names
More detailed information about this field from each metasource.
FDA's Adverse Event Reporting System
metasource: Fairsharing.orgversion: None
FAERS
metasource: Fairsharing.orgversion: None
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
faers
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
Names
More detailed information about this field from each metasource.
FDA's Adverse Event Reporting System
metasource: Fairsharing.orgversion: None
FAERS
metasource: Fairsharing.orgversion: None
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
faers
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
The FDA Adverse Event Reporting System (FAERS) is a database that contains information on adverse event and medication error reports submitted to FDA.
Description
More detailed information about this field from each metasource.
The FDA Adverse Event Reporting System (FAERS) is a database that contains information on adverse event and medication error reports submitted to FDA.
metasource: Fairsharing.orgversion: None
Comparing drug safety of hepatitis C therapies using post-market data. FAERS Quarterly Data Extract Files. U.S. Department of Health and Human Services. FDA Adverse Event Reporting System (FAERS) Quarterly Data Extract Files. A simple search of FAERS data cannot be performed with these files by persons who are not familiar with creation of relational databases. However, you can get a summary FAERS report for a product by sending a Freedom of Information Act (FOIA) request to FDA. You can also request individual case reports by submitting a FOIA request listing case report numbers.
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
Webpage:
https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faersWebpage
More detailed information about this field from each metasource.
https://www.fda.gov/drugs/surveillance/questions-and-answers-fdas-adverse-event-reporting-system-faers
metasource: Fairsharing.orgversion: None
https://fis.fda.gov/extensions/FPD-QDE-FAERS/FPD-QDE-FAERS.html
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
Licence:
Name: FAERS disclaimerLicence name
More detailed information about this field from each metasource.Licence URL
More detailed information about this field from each metasource.
https://fis.fda.gov/sense/app/d10be6bb-494e-4cd2-82e4-0135608ddc13/sheet/7a47a261-d58b-4203-a8aa-6d3021737452/state/analysis
metasource: Fairsharing.orgversion: None
Publications:
Publications
More detailed information about this field from each metasource.
Comparing drug safety of hepatitis C therapies using post-market data
PMID: 31391106
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
Publications
More detailed information about this field from each metasource.
Comparing drug safety of hepatitis C therapies using post-market data
PMID: 31391106
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
-
Comparing drug safety of hepatitis C therapies using post-market data
PubMed citations: 3.
3 articles citing: Comparing drug safety of hepatitis C therapies using post-market data
Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase. PMID:33883523
Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study. PMID:32530430
Anticholinergic Burden and Safety Outcomes in Older Patients with Chronic Hepatitis C: A Retrospective Cohort Study. PMID:32466526
Tags:
Tags
More detailed information about this field from each metasource.
drug report
metasource: Fairsharing.org
version: None
safety sciences
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
surgery
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
allergy, clinical immunology and immunotherapeutics
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
preclinical and clinical studies
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
public health and epidemiology
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
rare diseases
metasource: bio.tools
version: extracted_at: 2022-11-04T11:26:43.480175
Tags
More detailed information about this field from each metasource.
drug report
metasource: Fairsharing.orgversion: None
safety sciences
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
surgery
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
allergy, clinical immunology and immunotherapeutics
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
preclinical and clinical studies
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
public health and epidemiology
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
rare diseases
metasource: bio.toolsversion: extracted_at: 2022-11-04T11:26:43.480175
drug report safety sciences surgery allergy, clinical immunology and immunotherapeutics preclinical and clinical studies public health and epidemiology rare diseases
Need help integrating and/or managing biomedical data?